-
Mashup Score: 1Open Letter from TNAAP - 2 year(s) ago
The Honorable Governor Lee, Lt. Gov. McNally, and Speaker Sexton: As Tennessee healthcare professionals, we remain devastated by the horrific events at the Covenant School this Monday in Nashville where 3 children and 3 adults were killed. This latest school shooting, the 39th this year, will forever change the lives of the children, families, community members and all of those impacted by this…
Source: openletter.earthCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2
by Bill Snyder Four Vanderbilt University Medical Center faculty members have been elected this year to membership in the American Society for Clinical Investigation (ASCI), the organization has announced. Four others from VUMC have received ASCI Council Young Physician Scientist Awards this year, and two have received ASCI Emerging Generation Awards. Founded in 1908, the…
Source: Vanderbilt UniversityCategories: Latest Headlines, Oncologists2Tweet-
RT @KimrynRathmell: American Society for Clinical Investigation @the_asci honors 10 Vanderbilt physicians https://t.co/3NhS2Ja7LI via @vumc…
-
-
Mashup Score: 2Study sheds light on the development of inflammation, high blood pressure and resulting kidney damage. - 3 year(s) ago
by Bill Snyder Researchers at Vanderbilt University Medical Center have found that the change in a single letter of the genetic code promotes, in a mouse model, the development of inflammation, high blood pressure and resulting kidney damage. Their findings, featured Oct. 14 on the cover of Circulation Research, suggest that targeting inflammatory cytokines, signaling…
Source: Vanderbilt UniversityCategories: Latest Headlines, Oncologists2Tweet-
Great highlight for Meena Madhur @CVimmunology, Xue Zhong @xzhong12, & @VUMC_MedPSTP alum Matt Alexander @VascRes on their work with inflammation and #hypertension! https://t.co/DIOJP3A6we
-
-
Mashup Score: 1Tasty Bite - 3 year(s) ago
Search by product to find a Tasty Bite retailer near you.
Source: www.tastybite.comCategories: Latest Headlines, Oncologists2Tweet-
RT @TastyBite: @BGriebMD @jayccarnes Hi Brian, find a store near you here: https://t.co/wzd1rbHtLc
-
-
Mashup Score: 9Hu named to direct Office for Medical Student Research - 3 year(s) ago
Patrick Hu, MD PhD, associate professor of Medicine and Cell and Developmental Biology, has been named assistant dean for Physician-Researcher Training and director of the Office for Medical Student Research.
Source: Vanderbilt UniversityCategories: Hem/Oncs, Latest HeadlinesTweet-
Well-deserved honor for @patrickhu of @VUMC_Cancer @VUMCHemOnc Hu named to direct Office for Medical Student Research https://t.co/8lYRQ0J2SV via @vumchealth
-
A win for @VUmedicine with @patrickhu getting students plugged into the amazing research opportunities at @VUMChealth! https://t.co/Fxk24VtvN8
-
-
Mashup Score: 2
New research from Vanderbilt could aid efforts to promote kidney regeneration after injury or to develop engineered organs.
Source: Vanderbilt UniversityCategories: Latest Headlines, Oncologists2Tweet-
Congratulations to @VUMC_MedPSTP scholar Fabian Bock of @VUMCKidney on his amazing work! Harrison Society researcher discovers key regulator of kidney cell structure | VUMC Reporter | Vanderbilt University https://t.co/FVpeXlne26
-
-
Mashup Score: 1Shifts in neuroendocrine cancer clinical trial design - 4 year(s) ago
Clinical trials that focus on specific types of neuroendocrine neoplasms — heterogeneous tumors that can occur anywhere in the body — will be more likely to enhance drug development for these tumors, Vanderbilt physicians assert.
Source: Vanderbilt UniversityCategories: Latest Headlines, Oncologists2Tweet-
Great work by @nanudasmd on clinical trail design and drug development for patients with neuroendocrine tumors! @VUMC_Cancer.@VUMCHemOnc @benhopark Shifts in neuroendocrine cancer clinical trial design https://t.co/p0K1psA7ku
-
-
Mashup Score: 15HER2-Directed Therapy in Advanced Gastric and Gastroesophageal Adenocarcinoma: Triumphs and Troubles - Current Treatment Options in Oncology - 4 year(s) ago
Gastric and gastroesophageal junction (GEJ) cancers represent the third leading cause of malignancy-associated death worldwide. Approximately 15–20% of these adenocarcinomas overexpress the human epidermal growth factor receptor 2 (HER2), a pro-proliferative receptor tyrosine kinase that has been therapeutically exploited in other disease contexts. The landmark ToGA trial demonstrated that…
Categories: Latest Headlines, Oncologists2Tweet-
Excited to share a review co-authored with @RajivAgarwalMD on HER2-directed therapies for advanced gastric & gastroesophageal adenocarcinoma. https://t.co/IpOvbPeFMI @jordanberlin5 @VUMCHemOnc @VUMC_Cancer @VUMC_MedPSTP @VUMC_Medicine https://t.co/P8rLKTi8Sp
-
I usually stay out of politics on Twitter, but I cried Wednesday after dropping my kids off at their daycare just down the street from the Covenant School. TN healthcare workers, consider signing this letter supporting gun reforms. TNAAP Open Letter https://t.co/GlGWUAtU5o